Johnson & Johnson has agreed to acquire V-Wave Ltd., a medical device company focused on developing treatments for people with heart failure and cardiovascular disease, for approximately $1.1 billion. The transaction, announced Aug. 20, is expected to close before the end of 2024. Caesarea, Israel-based V-Wave was represented by a Kirkland & Ellis team led by corporate partners Lauren Colasacco, Daniel Wolf and Jimin He and tax partner Sara Zablotney. Counsel information for Johnson & Johnson was not immediately available.
Biotech & Pharmaceuticals
August 21, 2024, 9:33 AM